Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Migraine Prevention Efficacy: Individualization of Treatment by Coupling Drug's Mode of Action With Patient's Mechanism of Pain Modulation

NCT02101892 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT02101892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02101892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Migraine Prevention Efficacy: Individualization of Treatment by Coupling Drug's Mode of Action With Patient's Mechanism of Pain Modulation
Lead sponsor
Rambam Health Care Campus
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2014
Completion date
February 29, 2016
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, preventive treatment